Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.28 (
chloramphenicol acetyltransferase
)
5,100
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The X gene of human hepatitis B virus encodes the polypeptide HBx which transactivates viral and host genes through a variety of cis-acting enhancer elements present in RNA polymerases I, II and III promoters. To better understand the mechanism of X transactivation, we cloned cDNAs of proteins that bind HBx. Here we demonstrate that one of these cDNAs is a full-length cDNA of human
RPB5
, a subunit shared by RNA polymerases. The HBx transactivation domain and the central region of human
RPB5
were necessary for the specific binding of the two proteins as shown by: (i) in vitro assays using deletion mutants of fusion proteins; (ii) in vivo assays which detect associated proteins by co-immunoprecipitation of the non-fused proteins from transfected HepG2 cells. Over-expressed HBx seemed to associate with assembled forms of endogenous human
RPB5
in HBx-transfected cells, since the endogenous
RPB5
co-immunoprecipitated with HBx. The HBx binding region of human
RPB5
by itself stimulated
chloramphenicol acetyltransferase
activities from several different reporters having X-responsive element(s). Our results support the idea that the interaction of HBx and human
RPB5
can facilitate HBx transactivation and that human
RPB5
has a domain which can communicate with transcriptional regulators.
...
PMID:Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. 782 86